comparemela.com

Latest Breaking News On - Thomas rudel - Page 4 : comparemela.com

Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19

Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with

Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic . Aeterna Zentaris IncFebruary 2, 2021 GMT - Company secures next step to continue to build-out pipeline of assets - University researchers developed a proprietary and orally active bacterial vaccine platform technology currently undergoing pre-clinical studies for the prevention of coronavirus diseases, including COVID-19 - Aeterna Zentaris to evaluate the University’s coronavirus vaccine platform technology including COVID-19 under an exclusive option agreement CHARLESTON, S.C., Feb. 02, 2021 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), through its wholly-owned subsidiary Aeterna Zentaris GmbH, (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.